Canopy Biosciences exclusively licenses technology for error correction in NGS from Washington University

March 11, 2019 Leave a comment 2,767 Views

Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Canopy Biosciences

Canopy Biosciences exclusively licenses technology for error correction in NGS from Washington University

DirectRMDB – a database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology

Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq

MATQ_Drop – Multiple-Annealing-and-Tailing-based Quantitative scRNA-seq in Droplets

Featured RNA-Seq Job – Research Technician II – Single Cell RNA Sequencing

IMMUcan scDB – a fully integrated scRNA-seq database exclusively dedicated to human cancer

Correspondence analysis for dimension reduction, batch integration, and visualization of single-cell RNA-seq data

Mutant KRAS signaling drives alternative splicing in lung cancer cells